Basic Information
Basic information for SOX9-AS1-239-18aa-2
Peptide Name SOX9-AS1-239-18aa-2
Genome Position chr17:72075941-72075994[-]
Species Human
Peptide Sequence MKTNSSWIIERRQLREQF
Peptide Length 18
Unique No (SOX9-AS1-204-18aa-2,SOX9-AS1-213-18aa-1,SOX9-AS1-220-18aa-1,SOX9-AS1-223-18aa,SOX9-AS1-225-18aa-1,SOX9-AS1-228-18aa-2,SOX9-AS1-229-18aa-1,SOX9-AS1-231-18aa-1,SOX9-AS1-232-18aa-2,SOX9-AS1-234-18aa-2,SOX9-AS1-237-18aa-2)
Grand Average of Hydropathicity -1.1444
Relative Molecular Mass 2628.94
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000671151;SOX9-AS1-239
Transcript Length 1258
Coding Ability 0.6407
DNA Sequence Corresponding to Peptide ATGAAGACTAACAGCTCTTGGATAATTGAGAGAAGGCAGCTGCGTGAACAGTTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :